 |
|
Home | Equities Research Analysts’ Price Target Changes for January, 17th (ACT, ASBC, AUY, BBT, BJRI, CADX, CDE, CSX, DHR, EGO) |
 |
Equities Research Analysts’ Price Target Changes for January, 17th (ACT, ASBC, AUY, BBT, BJRI, CADX, CDE, CSX, DHR, EGO)
|
 |
- January 17, 2014
-
Equities Research Analysts’ price target changes for Friday, January 17th: Actavis (NYSE:ACT) had its target price raised by Argus from $180.00 to $198.00. The firm currently has a buy rating on the stock. Associated Banc-Corp (NASDAQ:ASBC) had its price target boosted by Credit Suisse from $15.00 to $17.00. Yamana Gold (NYSE:AUY) had its price target […]This article (Equities Research Analysts’ Price Target Changes for January, 17th (ACT, ASBC, AUY, BBT, BJRI, CADX, CDE, CSX, DHR, EGO)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/01/17/equities-research-analysts-price-target-changes-for-january-17th-act-asbc-auy-bbt-bjri-cadx-cde-csx-dhr-ego/
- National Radon Month is going on, don't ignore the Radon Gas Threat. Give your Radon Mitigation Company a call
- Radon Awareness Month has started. Don't ignore the potential radon threat in your home. Call a radon specialist now
- Investment Analysts’ Upgrades for January, 17th (AMRE, ARC, EGL, FF, FIG, JACK, NLST, NRF, NX, ORBK)
- GlaxoSmithKline Reaches New 12-Month High at $54.20 (GSK)
|
 |
|
 |
|
 |
